Trial Profile
A randomized, multicenter, double-blind, placebo-controlled crossover study to assess the efficacy of two doses of EVT 201 in the treatment of primary insomnia in adult patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Dimdazenil (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Evotec SE
- 05 Sep 2007 Status change from in progress to completed
- 04 Jun 2007 Status changed from recruiting to in progress (media release 9076441)
- 01 Feb 2007 New trial centre added.